ATP5F1B and cancer: Additionally, the challenges of the utilization of shrimp lncRNA06 in clinics, such as the preclinical studies using the full-length shrimp incRNA06 or its binding sites for miR-17-5p and ATP5F1B and the development of effective delivery methods for lncRNA-based therapies in cancer, needed to be further investigated.